Skip to main content

Table 3 Correlation of tumor subgroups with clinical parameters

From: Colon cancer molecular subtypes identified by expression profiling and associatedto stroma, mucinous type and different clinical behavior

Parameter   Cluster-1 (n = 35) Cluster-2 (n = 12) Cluster-3 (n = 22) Cluster-4 (n = 14) p-global
Microsatellite instability MSS 33 11 21 9 0.039LR,a
  MSI 2 1 1 5  
Histologic subtypes Conventional 34 12 21 8 0.001LR,b
  Mucinous 1 0 1 6  
% Stroma content frozen sample Mean 11.2 18.8 23.4 18.9 <0.001KW,c
  SD 6.0 10.3 10.5 14.8  
% Stroma Paraffin Mean 12.6 17.1 18.9 16.8 0.047KW,d
  SD 6.0 9.9 8.6 14.2  
nuclear β-Catenin (IHC) LOW 21 9 11 12 0.021LR,e
  MEDIUM 4 0 6 1  
  HIGH 10 2 5 0  
BRAF mutations (V600E) Mutated 0 1 1 6 <0.001LR,f
  WT 35 11 21 8  
Dukes Stage A 9 5 4 4 0.646LR
  B 9 3 6 7  
  C 8 2 6 2  
  D 9 2 6 1  
  1. LR: Likelihood Ratio. KW: Kruskal Wallis. Pair wise comparisons: a:C4 ≠ C1 (0.015); C4 ≠ C3(0.024); b: C4 ≠ C1 (0.001);C2 ≠ C4 (0.017); C4 ≠ C3(0.008); c: C1 ≠ C4 (0.013);C1 ≠ C2 (0.020); C1 ≠ C3 (<0.001); d: C1 ≠ C3 (0.005); e:C1 ≠ C4 (0.020); C2 ≠ C3(0.047); C3 ≠ C4 (0.014); f:C4 ≠ C1 (<0.001); C4 ≠ C2(<0.081); C4 ≠ C3 (0.008); Frozen stroma vsparaffin ICC of 0.781 (IC95% 0.681-0.852)p < 0.001.